BRCA1/2 gene mutations are the most critical genetic susceptibility genes leading to breast cancer. BRCA1/2 coding region mutations increase the risk of breast and ovarian cancer, while BRCA1/2 is passed on to offspring, resulting in aggregation of multiple tumors in families with BRCA1/2 mutations. The results of BRCA1/2 testing will provide important guidance for better treatment, the blocking of unwanted genetic transfer, early diagnosis and the prevention of related tumors at later stages.

QuarMultiple BRCA Amplicon is designed for multiple PCR based targeted sequencing. It can specifically amplify the target region in a short period of time, providing a convenient and effective way for BRCA detection.